Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 795
Filtrar
1.
Hematology ; 29(1): 2412949, 2024 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-39383031

RESUMEN

OBJECTIVE: To describe a novel α-thalassemiadeletion identified from a newborn by third-generation sequencing (TGS). CASE REPORT: The proband, a newborn subject to neonatal capillary electrophoresis (CE) screening, exhibited suspected α0-thalassemia carrier status (Hb Bart's 3.0%). Notably, both parents had negative results on thalassemia screening during pregnancy. Multiplex ligation-dependent probe amplification (MLPA) presented a deletion between probes 364nt and 472 nt that extended from the HBZ gene to the downstream region of the RGS11 gene. Subsequently, TGS determined the approximated break position of this deletion, indicating a length exceeding 145 kb (chr16:127,815-273,190 del 145376 bp). Sanger sequencing validated the upstream and downstream breakpoints of this deletion. Only maternal data were available for pedigree analysis, with the father's sample lacking. MLPA showed no deletion in the mother, suggesting possible paternal inheritance. The deletion was named Guigang deletion (--Guigang) after the proband's city of origin, Guigang. CONCLUSIONS: We reported a novel α-thalassemiadeletion and provided insights into the hematological phenotype and molecular analysis. These findings have implications for genetic counseling and prenatal diagnosis.


Asunto(s)
Eliminación de Secuencia , Globinas alfa , Talasemia alfa , Humanos , Recién Nacido , Globinas alfa/genética , Femenino , Talasemia alfa/genética , Talasemia alfa/diagnóstico , Familia de Multigenes , Masculino , Secuenciación de Nucleótidos de Alto Rendimiento , Pueblos del Este de Asia
2.
BMC Med Genomics ; 17(1): 241, 2024 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-39354459

RESUMEN

BACKGROUND: Third-generation sequencing (TGS) based on long-read technology has been gradually used in identifying thalassemia and hemoglobin (Hb) variants. The aim of the present study was to explore genotype varieties of thalassemia and Hb variants in Quanzhou region of Southeast China by TGS. METHODS: Included in this study were 6,174 subjects with thalassemia traits from Quanzhou region of Southeast China. All of them underwent common thalassemia gene testing using the DNA reverse dot-blot hybridization technology. Subjects who were suspected as rare thalassemia carriers were further subjected to TGS to identify rare or novel α- and ß-globin gene variants, and the results were verified by Sanger sequencing and/or gap PCR. RESULTS: Of the 6,174 included subjects, 2,390 (38.71%) were identified as α- and ß-globin gene mutation carriers, including 40 carrying rare or novel α- and ß-thalassemia mutations. The αCD30(-GAG)α and Hb Lepore-Boston-Washington were first reported in Fujian province Southeast China. Moreover, the ßCD15(TGG> TAG), ßIVS-II-761, ß0-Filipino(~ 45 kb deletion), and Hb Lepore-Quanzhou were first identified in the Chinese population. In addition, 35 cases of Hb variants were detected, the rare Hb variants of Hb Jilin and Hb Beijing were first reported in Fujian province of China. Among them, one case with compound αααanti3.7 and Hb G-Honolulu variants was identified in this study. CONCLUSION: Our findings may provide valuable data for enriching the spectrum of thalassemia and highlight the clinical application value of TGS-based α- and ß-globin genetic testing.


Asunto(s)
Globinas alfa , Globinas beta , Humanos , Globinas beta/genética , Globinas alfa/genética , China , Femenino , Masculino , Adulto , Secuenciación de Nucleótidos de Alto Rendimiento , Mutación , Adolescente , Niño , Talasemia/genética , Adulto Joven , Talasemia beta/genética , Genotipo , Persona de Mediana Edad , Talasemia alfa/genética , Pueblos del Este de Asia
3.
Hemoglobin ; 48(4): 280-284, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-39415483

RESUMEN

We report a novel mutation on α2-globin gene leading to an elongated α-chain. This novel frameshift mutation was detected in a 13-year-old boy from Balkh province, Afghanistan. DNA analysis identified an insertion of thymine (T) at codon 132 [HBA2:c.396dup (p.Val134fs)]. We named the novel hemoglobin variant 'Hemoglobin Balkh' after the geographic location from which the patient originated. This novel variant was found in association with α3.7 kb α-globin gene deletion, suggesting a compound heterozygous state that contributes to the patient's clinical presentation.


Asunto(s)
Codón , Mutación del Sistema de Lectura , Hemoglobinas Anormales , Globinas alfa , Humanos , Masculino , Globinas alfa/genética , Hemoglobinas Anormales/genética , Adolescente , Mutación , Talasemia alfa/genética , Talasemia alfa/diagnóstico , Heterocigoto
4.
Blood ; 144(15): 1554-1556, 2024 Oct 10.
Artículo en Inglés | MEDLINE | ID: mdl-39388159
5.
Hematology ; 29(1): 2399361, 2024 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-39263910

RESUMEN

OBJECTIVE: The α-globin fusion gene between the HBA2 and HBAP1 genes, is clinically important in thalassemia screening because this fusion gene can cause severe hemoglobin (Hb) H disease when combined with α0 -thalassemia (α0 -thal). In this study, we evaluate the red blood cell parameters of α-thalassemia fusion gene in southern China. METHOD: Study samples suspected of α-thalassemia fusion gene were collected and confirmed by PCR-sequencing from one medical lab center in southern China. Their genotypes and phenotypes were analyzed. RESULTS: A total of 266 cases of α-thalassemia fusion gene were confirmed in our lab from 2017 to 2023, most of them were from Hainan province (169 cases) and Huadu district of Guangzhou (21 cases), the nationality of 143 cases from Hainan was identified, with 71.3% (102/143) being from the Li minority. The Hb, MCV, MCH for αα/(αα)fusion in adult males were 143.5±11.83g/L, 81.51±4.39 fl, and 26.26±1.29 pg, respectively; and in females, they were 126.69±12.89 g/L, 80.10±4.05 fl, 25.8±2.04 pg, respectively. All 12 cases (αα) Fusion/ --SEA showed anemia with decreased Hb, MCV and MCH. CONCLUSION: The carriers of α-globin fusion gene heterozygotes are clinically silent and exhibit an α+ phenotype. Individuals with (αα)Fusion/--SEA show apparent anemia. This α-globin fusion gene is relatively common in southern China, specifically among the Li minority of Hainan province. Therefore, it should be taken into account for genetic counseling purposes.


Asunto(s)
Genotipo , Fenotipo , Talasemia alfa , Humanos , Talasemia alfa/genética , Talasemia alfa/epidemiología , Masculino , Femenino , China/epidemiología , Adulto , Globinas alfa/genética , Persona de Mediana Edad , Niño , Adolescente , Adulto Joven
6.
Hematology ; 29(1): 2399356, 2024 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-39252479

RESUMEN

BACKGROUND: Thalassemias are genetic disorders of globin chain synthesis. In Iraq, ß-thalassemia is more prevalent than α-thalassemia. This study identifies two unpredicted globin gene mutations, a rare α-globin gene mutation (Hb SKMC) and a novel γδß-thalassemia deletion. METHODS: Over 2 years, the Genetics unit at PAR hospital in Erbil, northern Iraq processed 137 ß-thalassemia and 97 α-thalassemia genetic testing requests. Three symptomatic thalassemia cases with unreported genotypes were identified. Proband-1α and proband-2α had Hb H disease, while proband-1ß had severe transfusion-dependent ß-thalassemia (TDT). Molecular studies included multiplex PCR, reverse hybridization, multiplex ligation-dependent probe amplification (MLPA), and globin gene sequencing. RESULTS: The α-thalassemia probands exhibited moderate microcytic hypochromic anemia with irregular transfusions and splenomegaly. Hb H disease was confirmed by positive Hb H tests and high-performance liquid chromatography (HPLC). Molecular analysis revealed heterozygous -MED deletion in proband-1α and α2Poly-A2 mutation in proband-2α. Sequencing identified the Hb SKMC (HBA1:c.283_300+3dup) mutation in both probands. The ß-thalassemia proband showed anemia and regular transfusions. Molecular studies detected the IVS1.110 G>A mutation and a novel γδß-thalassemia deletion in compound heterozygous form. The maternal sample showed the IVS1.110 G>A mutation, and MLPA confirmed the γδß-thalassemia deletion in the paternal sample. CONCLUSION: These findings highlight the genetic diversity of thalassemias in the region and emphasize the importance of advanced molecular diagnostics in detecting rare mutations.


Asunto(s)
Talasemia beta , Humanos , Irak , Talasemia beta/genética , Masculino , Femenino , Mutación , Adulto , Globinas alfa/genética , Talasemia alfa/genética , Talasemia delta/genética , Hemoglobinas Anormales/genética
7.
Libyan J Med ; 19(1): 2406620, 2024 Dec 31.
Artículo en Inglés | MEDLINE | ID: mdl-39312720

RESUMEN

To determine the molecular basis, genotype - phenotype relationship, and genetic origin of Hemoglobin (Hb) Hekinan associated with several forms of α-thalassemia and other hemoglobinopathies for a better understanding of its diverse clinical phenotypes. Seventeen participants with suspected abnormal Hb were studied. Hb analysis was performed using high-performance liquid chromatography (HPLC) and capillary electrophoresis (CE). Mutational and α-haplotypic and structural analyses were conducted, and the effects of mutations on globin-chain stability were determined. All participants harbored Hb Hekinan II (HBA1:c.84 G>T) co-inherited with another α-globin gene anomaly. Three novel genotypes, (ααHekinan/αCSα), (ααHekinan/αCSα,ßA/ßE), and (ααHekinan/αCSα,ßE/ßE), were characterized. Despite being co-inherited with both α- and ß-Hb variants Hb Hekinan II led to minimal changes in erythrocyte parameters, suggesting a non-pathological nature. HPLC but not CE revealed a distinct small shoulder-like Hb pattern. Thai Hb Hekinan II was strongly associated with haplotype [+ - S + - - -] and the possibility of four different haplotypes, while two Burmese Hb Hekinan II were associated with haplotypes [± - S + - + -] and [± - S + - - -]. The novel genotypes identified provide a fresh perspective on Hb Hekinan II diversity. HPLC has superior identification capabilities for samples of Hb Hekinan II co-inherited with α-thalassemia. Thai and Burmese Hb Hekinan II have diverse origins.


Asunto(s)
Electroforesis Capilar , Hemoglobinopatías , Hemoglobinas Anormales , Talasemia alfa , Adolescente , Adulto , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Globinas alfa/genética , Talasemia alfa/genética , Talasemia alfa/sangre , Cromatografía Líquida de Alta Presión , Estudios de Asociación Genética , Genotipo , Haplotipos , Hemoglobinopatías/genética , Hemoglobinopatías/sangre , Hemoglobinas Anormales/genética , Mutación , Fenotipo , Tailandia
8.
Malays J Pathol ; 46(2): 321-324, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-39207010

RESUMEN

INTRODUCTION: Haemoglobin (Hb) Quong Sze is a non-deletional α-thalassaemia subtype that occurs due to missense mutation at codon 125 of the HBA2 gene. Interaction between Hb QS with Southeast Asian double α-globin gene deletion results in non-deletional HbH disease, which is more severe than deletional HbH. CASE REPORT: A 3-month-old baby boy was presented with neonatal anaemia and mild hepatomegaly. Full blood count revealed severe hypochromic microcytic anaemia. There was an abundance of HbH inclusion bodies in his red blood cells. High-performance liquid chromatography showed a reduced HbA2 level with the presence of pre-run peak. Capillary electrophoresis showed the presence of HbH and Hb Barts. Molecular analysis found a common α0-thalassaemia (--SEA) in one allele and mutation in codon 125 in the other allele. DISCUSSION: Non-deletional HbH disease due to a combination of deletional and non-deletional mutations may present with severe clinical manifestations than those with deletion mutations, which warrants accurate diagnosis using molecular techniques.


Asunto(s)
Eliminación de Gen , Hemoglobinas Anormales , Globinas alfa , Talasemia alfa , Humanos , Masculino , Hemoglobinas Anormales/genética , Globinas alfa/genética , Talasemia alfa/genética , Talasemia alfa/diagnóstico , Lactante , Heterocigoto , Malasia , Pueblos del Sudeste Asiático
9.
Int J Mol Sci ; 25(16)2024 Aug 06.
Artículo en Inglés | MEDLINE | ID: mdl-39201263

RESUMEN

Hemoglobin Shaare Zedek (Hb SZ) is a rare structural α-Hb variant. Characterizing its genotype-phenotype relationship and genetic origin enhances diagnostic and clinical management insights. We studied a proband and six family members using high-performance liquid chromatography (HPLC), capillary electrophoresis (CE), PCR, and sequencing to analyze α- and ß-globin genes and α-globin haplotypes. Pathogenicity predictions and a rapid diagnostic method were developed. The proband, his father, grandfather, and aunt had Hb migrating to the HbH-zone on CE and elevated fetal hemoglobin (HbF) on HPLC. Direct sequencing identified an A to G mutation at codon 56 of the α2-globin gene, characteristic of Hb SZ. Additionally, the proband carried a ß-globin gene mutation [HBB.52A>T]. Mild thalassemia-like changes were observed in the proband, whereas individuals with only the Hb SZ variant did not exhibit these changes. Pathogenicity predictions indicated that Hb SZ is benign. The variant can be identified using restriction fragment length polymorphism (RFLP) and allele-specific PCR. The Thai variant of Hb SZ is associated with the haplotype [- - M - - - -]. Hb SZ is a non-pathological variant that minimally affects red blood cell parameters, even when it coexists with ß0-thalassemia. HPLC and CE systems cannot distinguish it from other Hbs, necessitating DNA analysis for accurate diagnosis.


Asunto(s)
Hemoglobinas Anormales , Globinas beta , Talasemia beta , Adulto , Femenino , Humanos , Masculino , Globinas alfa/genética , Globinas beta/genética , Talasemia beta/genética , Talasemia beta/diagnóstico , Haplotipos , Hemoglobinas Anormales/genética , Mutación , Electroforesis Capilar , Cromatografía Líquida de Alta Presión
11.
Arch Med Res ; 55(6): 103055, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-39029212

RESUMEN

BACKGROUND: Excessive expression of hemoglobin F (HbF) is a characteristic feature and important diagnostic marker of ß0-thalassemia/HbE disease. However, some patients may exhibit low-HbF levels, leading to misdiagnosis and precluding genetic counseling. The genetic factors influencing these differences in HbF expression in this atypical disease are not completely understood. AIMS: To investigate determinants contributing to the non-elevation of HbF expression in ß0-thalassemia/HbE disease. METHODS: We studied 231 patients with ß0-thalassemia/HbE confirmed by DNA analysis; classified them into the low-HbF (n = 62) and high-HbF (n = 169) groups; analyzed hematological parameters and hemoglobin levels in both groups; and characterized mutations in ß- and α-globin genes and genetic variants in γ-globin promoters. RESULTS: Both groups showed similar rates of type ß0-thalassemia mutations but significantly different proportions of α-globin mutations: approximately 88.7% (95% confidence interval [CI] = 66.8-115.5) and 39.1% (95% CI = 30.2-49.7) in the low- and high-HbF groups, respectively. The results revealed single-nucleotide polymorphisms (SNPs) at -158 (C>T) in the Gγ-globin promoters and novel SNPs at the 5' untranslated region position 25 (G>A) in Aγ-globin promoters. The distribution of CC genotypes of the Gγ-globin promoter in the low-HbF group was significantly higher than that in the high-HbF group. CONCLUSIONS: Cases with HbE predominance with low-HbF levels and undetectable HbA may not be as conclusive as those with homozygous HbE until DNA analysis is performed. Concomitant inheritance of α-thalassemia is an important inherent factor modifying HbF expression in a typical ß0-thalassemia/HbE, and SNPs with the CC genotype in the Gγ-globin promoter may indicate unelevated HbF expression in patients with this disease.


Asunto(s)
Hemoglobina Fetal , Mutación , Polimorfismo de Nucleótido Simple , Regiones Promotoras Genéticas , Globinas alfa , Talasemia beta , gamma-Globinas , Humanos , Hemoglobina Fetal/genética , Hemoglobina Fetal/metabolismo , gamma-Globinas/genética , Masculino , Femenino , Talasemia beta/genética , Talasemia beta/sangre , Talasemia beta/diagnóstico , Globinas alfa/genética , Adulto , Niño , Adolescente , Hemoglobina E/genética , Preescolar , Adulto Joven , Persona de Mediana Edad
12.
Clin Lab ; 70(7)2024 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-38965958

RESUMEN

BACKGROUND: New hemoglobin (Hb) variants are constantly being updated as assays are developed and the testing population expands. Here, we report a novel Hb variant, named Hb Guigang. METHODS: Hemoglobin (Hb) analysis was analyzed by capillary electrophoresis (CE) and high-performance liquid chromatography (HPLC). Glycated hemoglobin was performed by CE and HPLC. Routine genetic analysis was done with Gap-PCR and PCR-reverse dot-blot hybridization. The hemoglobin variant was identified by Sanger sequencing. RESULTS: CE of three cases showed the presence of Hb variants in Zone 5 and Zone 12, respectively. HPLC indicated an elevated P3 peak, suggesting the possible presence of the Hb variant. Hb A1c was measured by CE and HPLC, and the results were 6.7% and 4.76%, respectively. Sanger sequencing confirmed an AAG˃AAT mutation at codon 90 of the HBA1 gene. This mutation was reported for the first time, and we named it Hb Guigang based on the proband's place of residence. CONCLUSIONS: Hb Guigang with normal hematological parameters was separated and quantified by CE, whereas HPLC suggested that Hb Guigang co-eluted with the P3 peaks and could not be quantified.


Asunto(s)
Electroforesis Capilar , Hemoglobina Glucada , Hemoglobinas Anormales , Globinas alfa , Humanos , Hemoglobinas Anormales/genética , Globinas alfa/genética , Cromatografía Líquida de Alta Presión , Hemoglobina Glucada/análisis , Hemoglobina Glucada/metabolismo , Masculino , Femenino , Mutación , Análisis Mutacional de ADN , Adulto
13.
Ann Hematol ; 103(9): 3805-3810, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-38990295

RESUMEN

Abnormality of three α-globin genes, either deletion or point mutation results in symptomatic Hemoglobin H (HbH) phenotype. Most of such cases of α-globin defects are inherited from the parents, de-novo cases are exceedingly rare. Herein, a case of HbH is reported where the proband inherited one α-globin gene with a point mutation (αEvanston) from the mother. This was associated with large de-novo deletion of chromosome 16p13.3 resulting in α-thalassemia and mental retardation (ATR-16) syndrome. This deletion also encompassed two α-globin genes from chromosome 16, eventually leading to --/ααEvanston genotype, explaining the clinical presentation of the proband. The challenges in screening of such cases and confirming the molecular diagnosis along with the mode of inheritance has been discussed.


Asunto(s)
Cromosomas Humanos Par 16 , Fenotipo , Talasemia alfa , Humanos , Talasemia alfa/genética , Talasemia alfa/complicaciones , Cromosomas Humanos Par 16/genética , Femenino , Masculino , Hemoglobina H/genética , Discapacidad Intelectual/genética , Hemoglobinas Anormales/genética , Mutación Puntual , Deleción Cromosómica , Globinas alfa/genética
14.
Am J Hematol ; 99(11): 2164-2177, 2024 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-39037279

RESUMEN

Alpha-thalassemia is an inherited blood disorder caused by impaired α-globin chain production, leading to anemia and other complications. Hemoglobin H (HbH) disease is caused by a combination of mutations generally affecting the expression of three of four α-globin alleles; disease severity is highly heterogeneous, largely driven by genotype. Notably, non-deletional mutations cause a greater degree of ineffective erythropoiesis and hemolysis, higher transfusion burden, and increased complication risks versus deletional mutations. There are limited treatment options for HbH disease, and effective therapies are needed. This review discusses the pathophysiology of HbH disease, current management strategies, unmet needs, and emerging treatment options.


Asunto(s)
Talasemia alfa , Talasemia alfa/terapia , Talasemia alfa/genética , Talasemia alfa/complicaciones , Humanos , Globinas alfa/genética , Costo de Enfermedad , Mutación , Manejo de la Enfermedad , Hemoglobina H/genética
15.
Hemoglobin ; 48(4): 244-249, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-39007770

RESUMEN

α-thalassemia major (α-TM) often causes Hb Bart's (c4) hydrops fetalis and severe obstetric complications in the mother. Step-wise screening for couples at risk of having offspring(s) affected by α-TM is the efficient prevention method but some rare genotypes of thalassemia cannot be detected. A 32-year-old male with low HbA2 (2.4%) and mild anemia was performed real-time PCR-based multicolor melting curve analysis (MMCA) because his wife was -SEA deletion carrier. The result of multiplex ligation-dependent probe amplification (MLPA) suggested the existence of -SEA deletion in the proband. A novel deletion of the α-globin gene cluster was found using self-designed MLPA probes combined with longer PCR, which was further accurately described to be 16.8Kb (hg38, Chr16:1,65,236-1,82,113) deletion by the third-generation sequencing. A fragment ranging from 1,53,226 to 1,54,538(GRch38/hg38) was identified which suggested the existence of the homologous recombination event. The third-generation sequencing is accurate and efficient in obtaining accurate information for complex structural variations.


Asunto(s)
Familia de Multigenes , Eliminación de Secuencia , Globinas alfa , Talasemia alfa , Humanos , Masculino , Adulto , Globinas alfa/genética , Talasemia alfa/genética , Talasemia alfa/diagnóstico , Secuenciación de Nucleótidos de Alto Rendimiento , Femenino
16.
Blood ; 144(15): 1633-1645, 2024 Oct 10.
Artículo en Inglés | MEDLINE | ID: mdl-38949981

RESUMEN

ABSTRACT: α-Thalassemia (AT) is one of the most commonly occurring inherited hematological diseases. However, few treatments are available, and allogeneic bone marrow transplantation is the only available therapeutic option for patients with severe AT. Research into AT has remained limited because of a lack of adult mouse models, with severe AT typically resulting in in utero lethality. By using a lipid nanoparticle (LNP) targeting the receptor CD117 and delivering a Cre messenger RNA (mRNACreLNPCD117), we were able to delete floxed α-globin genes at high efficiency in hematopoietic stem cells (HSC) ex vivo. These cells were then engrafted in the absence or presence of a novel α-globin-expressing lentiviral vector (ALS20αI). Myeloablated mice infused with mRNACreLNPCD117-treated HSC showed a complete knock out (KO) of α-globin genes. They showed a phenotype characterized by the synthesis of hemoglobin H (HbH; also known as ß-tetramers or ß4), aberrant erythropoiesis, and abnormal organ morphology, culminating in lethality ∼8 weeks after engraftment. Mice infused with mRNACreLNPCD117-treated HSC with at least 1 copy of ALS20αI survived long term with normalization of erythropoiesis, decreased production of HbH, and amelioration of the abnormal organ morphology. Furthermore, we tested ALS20αI in erythroid progenitors derived from α-globin-KO CD34+ cells and cells isolated from patients with both deletional and nondeletional HbH disease, demonstrating improvement in α-globin/ß-globin mRNA ratio and reduction in the formation of HbH by high-performance liquid chromatography. Our results demonstrate the broad applicability of LNP for disease modeling, characterization of a novel mouse model of severe AT, and the efficacy of ALS20αI for treating AT.


Asunto(s)
Modelos Animales de Enfermedad , Terapia Genética , Células Madre Hematopoyéticas , Lentivirus , Talasemia alfa , Animales , Terapia Genética/métodos , Ratones , Talasemia alfa/genética , Talasemia alfa/terapia , Lentivirus/genética , Células Madre Hematopoyéticas/metabolismo , Nanopartículas , Vectores Genéticos/genética , Vectores Genéticos/administración & dosificación , Globinas alfa/genética , Trasplante de Células Madre Hematopoyéticas , Humanos , Ratones Endogámicos C57BL
17.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 32(3): 836-840, 2024 Jun.
Artículo en Chino | MEDLINE | ID: mdl-38926976

RESUMEN

OBJECTIVE: To analyze the gene mutation types and frequence of thalassemia patients in Jingzhou area. METHODS: A total of 721 suspected thalassemia patients who were visited in Jingzhou Central Hospital from June 2019 to June 2022 were selected as the research objects. There were 204 males and 517 females. PCR-reverse dot hybridization method was used to analyze the types and frequencies of 23 common α or ß thalassemia gene mutations. RESULTS: Among the 721 patients with suspected thalassemia, 228 cases were positive for α or ß thalassemia gene, with a total positive rate of 31.62%, including 87 cases of α-thalassemia, accounting for 38.16%, and 140 cases of ß-thalassemia, accounting for 61.40%. There was 1 case of α ß complex thalassemia, accounting for 0.44%. A total of 4 types of α-thalassemia gene mutations were detected, all of which were deletion types, including αα/--SEA (64/87, 73.56%), αα/-α3.7 (14/87, 16.09%), --SEA /-α3.7 (7/87, 8.05%), αα/-α4.2 (2/87, 2.30%). Among 140 patients with ß-thalassemia, 138 were pure heterozygotes, and the genotypes of IVS-II-654M (63/140, 45.00%), CD41-42M (34/140, 24.29%), CD17M (18/140, 12.86%) and CD27-28M (10/140, 7.14%) accounted for 89.29% of all mutations (125/140), 2 cases of double heterozygosity (2/140, 1.43%) were found, no homozygous ß-thalassemia were detected; 1 case of αß complex thalassemia with genotype -α3.7/IVS-II-654M was found. The incidence of difference types of thalassemia was statistically significant (χ2=194.250, P < 0.001). The percentage of positive thalassemia genes was not significantly difference between male and female suspected patients (χ2=0.199, P =0.655). CONCLUSION: The α-thalassemia gene mutation in Jingzhou area is dominated by αα/--SEA, and the IVS-II-654M mutation is more common in ß-thalassemia, and α ß complex thalassemia is relatively rare, which can provide a reference for the formulation of prevention and treatment measures for thalassemia in Jingzhou area.


Asunto(s)
Mutación , Talasemia alfa , Talasemia beta , Humanos , Masculino , Femenino , Talasemia alfa/genética , Talasemia alfa/epidemiología , Talasemia beta/genética , Talasemia beta/epidemiología , China/epidemiología , Heterocigoto , Globinas alfa/genética
18.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 32(3): 940-944, 2024 Jun.
Artículo en Chino | MEDLINE | ID: mdl-38926992

RESUMEN

OBJECTIVE: To perform molecular diagnosis and pedigree analysis for one case with α-thalassemia who does not conform to the genetic laws, and explore the effects of a newly discovered rare mutation (HBA2:c.*12G>A) on clinical phenotypes. METHODS: Blood samples of the proband and her family members were collected for blood routine analysis, and the hemoglobin components were analyzed by capillary electrophoresis. The common α- and ß-globin gene loci in Chinese population were detected by conventional techniques (Gap-PCR, RDB-PCR). The α-globin gene sequences (HBA1, HBA2) were analyzed by Sanger sequencing. RESULTS: By analyzing the test results of proband and her family members, the genotype of the proband was -α3.7/HBA2:c.*12G>A, her father was HBA2:c.*12G>A heterozygous mutation carrier. CONCLUSION: This study identifies a rare α-globin gene mutation (HBA2:c.*12G>A) that has not been reported before. It is found that heterozygous mutation carriers present with static α-thalassemia.


Asunto(s)
Hemoglobina A2 , Globinas alfa , Talasemia alfa , Femenino , Humanos , Masculino , Globinas alfa/genética , Talasemia alfa/genética , Talasemia alfa/diagnóstico , Genotipo , Hemoglobina A2/genética , Heterocigoto , Mutación , Linaje , Fenotipo , Pueblos del Este de Asia/genética
19.
Blood Adv ; 8(15): 4017-4024, 2024 Aug 13.
Artículo en Inglés | MEDLINE | ID: mdl-38861356

RESUMEN

ABSTRACT: ß-thalassemia is a condition characterized by reduced or absent synthesis of ß-globin resulting from genetic mutations, leading to expanded and ineffective erythropoiesis. Mitoxantrone has been widely used clinically as an antitumor agent considering its ability to inhibit cell proliferation. However, its therapeutic effect on expanded and ineffective erythropoiesis in ß-thalassemia is untested. We found that mitoxantrone decreased α-globin precipitates and ameliorated anemia, splenomegaly, and ineffective erythropoiesis in the HbbTh3/+ mouse model of ß-thalassemia intermedia. The partially reversed ineffective erythropoiesis is a consequence of effects on autophagy as mitochondrial retention and protein levels of mTOR, P62, and LC3 in reticulocytes decreased in mitoxantrone-treated HbbTh3/+ mice. These data provide significant preclinical evidence for targeting autophagy as a novel therapeutic approach for ß-thalassemia.


Asunto(s)
Modelos Animales de Enfermedad , Eritropoyesis , Mitoxantrona , Talasemia beta , Animales , Talasemia beta/tratamiento farmacológico , Eritropoyesis/efectos de los fármacos , Ratones , Mitoxantrona/farmacología , Mitoxantrona/uso terapéutico , Autofagia/efectos de los fármacos , Globinas alfa/genética , Reticulocitos/efectos de los fármacos , Reticulocitos/metabolismo
20.
Blood ; 144(8): 834-844, 2024 Aug 22.
Artículo en Inglés | MEDLINE | ID: mdl-38848504

RESUMEN

ABSTRACT: Red blood cells express high levels of hemoglobin A tetramer (α2ß2) to facilitate oxygen transport. Hemoglobin subunits and related proteins are also expressed at lower levels in other tissues across the animal kingdom. Physiological functions for most nonerythroid globins likely derive from their ability to catalyze reduction-oxidation (redox) reactions via electron transfer through heme-associated iron. An interesting example is illustrated by the recent discovery that α-globin without ß-globin is expressed in some arteriolar endothelial cells (ECs). α-globin binds EC nitric oxide (NO) synthase (eNOS) and degrades its enzymatic product NO, a potent vasodilator. Thus, depletion of α-globin in ECs or inhibition of its association with eNOS causes arteriolar relaxation and lowering of blood pressure in mice. Some of these findings have been replicated in isolated human blood vessels, and genetic studies are tractable in populations in which α-thalassemia alleles are prevalent. Two small studies identified associations between loss of α-globin genes in humans and NO-regulated vascular responses elicited by local hypoxia-induced blood flow or thermal stimulation. In a few larger population-based studies, no associations were detected between loss of α-globin genes and blood pressure, ischemic stroke, or pulmonary hypertension. In contrast, a significant positive association between α-globin gene copy number and kidney disease was detected in an African American cohort. Further studies are required to define comprehensively the expression of α-globin in different vascular beds and ascertain their overall impact on normal and pathological vascular physiology.


Asunto(s)
Globinas alfa , Humanos , Globinas alfa/genética , Globinas alfa/metabolismo , Animales , Óxido Nítrico/metabolismo , Células Endoteliales/metabolismo , Vasos Sanguíneos/metabolismo , Óxido Nítrico Sintasa de Tipo III/metabolismo , Óxido Nítrico Sintasa de Tipo III/genética , Ratones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...